Medicine & Life Sciences
Protein-Tyrosine Kinases
57%
Erlotinib Hydrochloride
48%
ErbB Receptors
36%
Non-Small Cell Lung Carcinoma
33%
tetramethylrhodamine
21%
Neoplasms
20%
Drug Evaluation
15%
Silicon
15%
Squamous Cell Carcinoma of Head and Neck
14%
Mitogen-Activated Protein Kinase Kinases
13%
Protein Domains
12%
Phosphatidylinositol 3-Kinases
12%
Mutagenesis
12%
Drug Interactions
12%
Heterografts
11%
Veins
10%
Pharmaceutical Preparations
10%
Fluorescence
10%
Phosphotransferases
9%
Pharmacokinetics
9%
Proteins
9%
Cell Membrane
9%
Immunohistochemistry
8%
Western Blotting
8%
Therapeutics
8%
Injections
7%
Physics & Astronomy
tyrosine
88%
inhibitors
73%
cancer
41%
evaluation
39%
drugs
25%
reagents
21%
lungs
20%
proteins
15%
tumors
12%
effectors
9%
mutagenesis
9%
veins
7%
therapy
6%
platforms
5%
fluorescence
4%
injection
4%
probes
3%
characterization
3%
cells
3%
silicon
3%
molecules
3%
interactions
2%
Chemical Compounds
Erlotinib
100%
Tyrosine Kinase Inhibitor
88%
Tetramethylrhodamine
30%
Protein
26%
Drug Target
24%
Effector
22%
Drug
22%
Resistance
13%
Plasma
12%
Probe
12%
Time
7%
Engineering & Materials Science
Imaging techniques
48%
Epidermal Growth Factor
32%
Reagents
22%
Proteins
17%
Tumors
12%
Heterografts
11%
Immunohistochemistry
10%
Mutagenesis
10%
Epithelial Cells
9%
Pharmacokinetics
8%
Cell membranes
8%
Assays
7%
Fluorescence
7%
Molecules
6%
Cells
6%
Plasmas
5%
Silicon
4%
Monitoring
3%